Congenital hyperinsulinism

Gene: NSD1

Green List (high evidence)

NSD1 (nuclear receptor binding SET domain protein 1)
EnsemblGeneIds (GRCh38): ENSG00000165671
EnsemblGeneIds (GRCh37): ENSG00000165671
OMIM: 606681, Gene2Phenotype
NSD1 is in 12 panels

4 reviews

Arina Puzriakova (Genomics England Curator)

Green List (high evidence)

The rating of this gene has been updated to Green following NHS Genomic Medicine Service approval.
Created: 31 Jan 2023, 4:38 p.m. | Last Modified: 31 Jan 2023, 4:38 p.m.
Panel Version: 2.32

Eleanor Williams (Genomics England Curator)

Review on behalf of Jayne Houghton and Kevin Colclough, Exeter Genomics Laboratory, SWGLH. Seven cases of hyperinsulinaemic hypoglycaemia with de novo NSD1 mutations have reported to date (Grand et al 2019 Am J Med Genet PMID:30719864). In addition, the Exeter laboratory has identified a further 3 cases referred with neonatal hypoglycaemia as part of a syndrome in which NSD1 de novo variants have been identified.
Created: 14 Sep 2022, 4:39 p.m. | Last Modified: 14 Sep 2022, 4:39 p.m.
Panel Version: 2.12

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Hyperinsulinaemic hypoglycaemia, distinctive facial features, overgrowth in childhood and developmental delay.

Publications

Ivone Leong (Genomics England Curator)

Comment on list classification: New gene added by Zornitza Stark (Australian Genomics). This gene is associated with a phenotype in OMIM and Gene2Phenotype (Definitive). There is enough evidence to support a gene-disease association. This gene should be rated Green at the next review.
Created: 3 Dec 2021, 4:14 p.m. | Last Modified: 3 Dec 2021, 4:14 p.m.
Panel Version: 2.8

Zornitza Stark (Australian Genomics)

Green List (high evidence)

Hyperinsulinism is a documented feature of this syndrome: at least 9 individuals with NSD1 variants and hyperinsulinism reported; persistent in 3/9/
Sources: Expert list
Created: 14 Feb 2020, 8:24 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Sotos syndrome (OMIM#117550)

Publications

Variants in this GENE are reported as part of current diagnostic practice

History Filter Activity

31 Jan 2023, Gel status: 3

Removed Tag, Removed Tag

Arina Puzriakova (Genomics England Curator)

Tag Q4_21_rating was removed from gene: NSD1. Tag Q3_22_NHS_review was removed from gene: NSD1.

31 Jan 2023, Gel status: 3

Added New Source, Added New Source, Status Update

Arina Puzriakova (Genomics England Curator)

Source Expert Review Green was added to NSD1. Source NHS GMS was added to NSD1. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

27 Sep 2022, Gel status: 2

Added Tag

Sarah Leigh (Genomics England Curator)

Tag Q3_22_NHS_review tag was added to gene: NSD1.

27 Sep 2022, Gel status: 2

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: NSD1 were changed from Sotos syndrome (OMIM#117550) to Sotos syndrome, OMIM:117550; Sotos syndrome 1, MONDO:0007299

3 Dec 2021, Gel status: 2

Added Tag

Ivone Leong (Genomics England Curator)

Tag Q4_21_rating tag was added to gene: NSD1.

3 Dec 2021, Gel status: 2

Entity classified by Genomics England curator

Ivone Leong (Genomics England Curator)

Gene: nsd1 has been classified as Amber List (Moderate Evidence).

14 Feb 2020, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Australian Genomics)

gene: NSD1 was added gene: NSD1 was added to Congenital hyperinsulinism. Sources: Expert list Mode of inheritance for gene: NSD1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: NSD1 were set to 30719864 Phenotypes for gene: NSD1 were set to Sotos syndrome (OMIM#117550) Review for gene: NSD1 was set to GREEN gene: NSD1 was marked as current diagnostic